The article you requested is
High-Dose Olanzapine Versus Clozapine
J Clin Psychiatry 2008;69:1660-1660 [letter]
Copyright 2008 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $30
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($129) or print + online ($166 individual).
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
Letter to the Editor
Sir: The article by Meltzer and colleagues1 suggesting
that high-dose olanzapine may be equivalent to clozapine in
treatment-resistant schizophrenics warrants some discussion.
The authors’ power analysis suggested that 17 patients per
group would be sufficient to provide 80% power. However, the
power analysis (as is often the case) did not consider dropouts,
and this was a particular concern in this study since 6 of 21 patients
receiving clozapine dropped out prior to 6 weeks.